United States· US:0075-8025_006561fa-e16d-4129-9dde-89c109b51d8f
Lovenox
A enoxaparin product containing enoxaparin sodium, registered in United States by Sanofi-Aventis U.S. LLC. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Enoxaparin is registered in 16 of 19 countries.
Countries holding a registration under ATC B01AB05 (enoxaparin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Enoxaparin · ATC B01AB05
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ENOXAPARIN SODIUM
- Manufacturer
- Sanofi-Aventis U.S. LLC
- Country
- United States (US)
- ATC code
- B01AB05
- ATC class
- Enoxaparin
- Defined daily dose
- 2 TSD, E
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11007580251010 CELLO PACK in 1 CARTON (0075-8025-10) / 1 SYRINGE in 1 CELLO PACK / 1 mL in 1 SYRINGE (0075-8025-01)
- ndc110075-8025-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for enoxaparin.
Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Enoxaparin · interactions on record
203 records
- 106 severe
- 73 moderate
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Enoxaparin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCLEXANESanofi s.r.o., Praha
- BelgiumClexane 10000 IU (100 mg)/1 mlSanofi Belgium
- CanadaAXBERIBAXTER CORPORATION
- IrelandClexane 10,000 IU (100 mg)/1 ml Solution for Injection in pre-filled syringesPCO Manufacturing Ltd.
- FinlandEnoxaparin BecatLaboratorios Farmacéuticos Rovi S.A.
- GermanyClexaneSanofi-Aventis Deutschland Gmbh
- SwedenEnoxaparin Becat 10 000 IE (100 mg)/1 ml Injektionsvätska, lösning i förfylld sprutaLaboratorios Farmacéuticos ROVI S.A.
- NorwayInhixaTechdow Pharma Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Enoxaparin Becat Laboratorios Farmacéuticos Rovi, Ghemaxan
- Belgium · Clexane, Enoxaparine Becat Laboratorios Farmacéuticos Rovi
- Bulgaria · Клексан
- Cyprus · Clexane, Ledraxen
- Czechia · Clexane, Clexane Forte
- Germany · Clexane, Clexane Klinik
- Denmark · Enoxaparin Becat Laboratorios Farmacéuticos Rovi, Ghemaxan
- Estonia · Clexane, Ledraxen
- Spain · Clexane, Crusia
- Finland · Enoxaparin Becat Laboratorios Farmacéuticos Rovi, Ghemaxan
- France · Crusia, Enoxaparine Arrow
- United Kingdom (Northern Ireland) · Arovi, Clexane Forte Syringes
- Greece · Clexane, Enoxaparin Rovi
- Croatia · Clexane, Ledraxen
- Hungary · Clexane, Clexane Forte
- Ireland · Clexane, Clexane Forte
- Iceland · Inhixa, Klexane
- Italy · Clexane, Clexane T
- Lithuania · Ledraxen
- Luxembourg · Clexane, Clexane 6 000 Ui
- Latvia · Clexane, Ledraxen
- Malta · Clexane, Clexane 2,000 Iu
- Netherlands · Enoxaparine Becat Laboratorios Farmacéuticos Rovi, Ghemaxan
- Norway · Enoxaparin Becat Laboratorios Farmacéuticos Rovi, Ghemaxan
- Poland · Clexane, Clexane Forte
- Portugal · Enoxaparina Rovi, Hepaxane
- Romania · Clexane, Hepaxane
- Sweden · Enoxaparin Becat Laboratorios Farmacéuticos Rovi, Ghemaxan
- Slovenia · Clexane, Enoksaparin Rovi
- Slovakia · Clexane, Clexane Forte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cc8ff09c-51df-449e-893d-17fa182dfabf GET /v1/drugs/cc8ff09c-51df-449e-893d-17fa182dfabf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "150",
"substance": "ENOXAPARIN SODIUM",
"productndc": "0075-8025",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA020164",
"marketing_category": "NDA"
}See everything about enoxaparin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.